摘要
目的冠状动脉内支架植入后并发出血的治疗及抗血小板药物的运用。方法选取2014年1月—2016年1月该院收治的340例冠状动脉内支架植入后并发出血患者,分为A、B、C 3组,A组210例患者给予阿司匹林、B组63例患者给予抵克力德得、C组67例患者给予血小板糖肽Ⅱb/Ⅲa受体拮抗剂,该次实验340例患者均采用肝素治疗,2周后观察比较患者治疗的出血情况以及并发症的发生率。结果 340例冠状动脉内支架植入后并发出血患者,给与抗血小板类药和适量给与抗凝药物治疗后,有效降低减少出血症状,总有效率为98.53%,达到有效止血的患者有335例。结论冠状动脉内支架植入后并发出血患者,给与抗血小板药治疗,可以有效减少出血症状的出现,适量给与抗凝类药物达到有效抗凝有效防止出血性血栓的发生,具有广泛的临床推广价值。
Objective Coronary stenting hemorrhagic complications after treatment and the use of antiplatelet drugs.Methods January 2014 to January 2016, our hospital 340 cases of coronary stent implantation in patients with bleeding, divided into A, B, C three groups, A group 210 patients were given aspirin, group B 63 patients were treated with ticlopidine group C 67 patients were given platelet glycoprotein peptide Ⅱb / Ⅲa receptor antagonist, this experiment340 cases of patients were treated with heparin, two weeks after the occurrence of relatively well patients bleeding complications rate. Results 340 cases with bleeding after coronary stent implantation in patients given anti-platelet drugs and the amount given anticoagulant therapy to effectively reduce reduce bleeding, the total effective rate was 98.53%,to a patient an effective hemostasis have 335 cases. Conclusion The coronary stent implantation in patients with bleeding after giving antiplatelet therapy, can effectively reduce the symptoms of bleeding, the amount given anticoagulant drugs to achieve effective anticoagulation effectively prevent bleeding thrombosis, with a wide range of clinical value.
出处
《系统医学》
2016年第11期55-57,共3页
Systems Medicine
